PharmiWeb.com - Global Pharma News & Resources

Press Releases

Date Title Company
12-Sep-2023 HUTCHMED Highlights Presentation of Results from the Phase IIIb Trial of Savolitinib at the 2023 World Conference of Lung Cancer HUTCHMED
12-Sep-2023 Critical agreement paves way for new model to accelerate access to important antibiotics for serious bacterial infections The Global Antibiotic Research & Development Partnership (GARDP) / Orchid Pharma Ltd (Orchid)
12-Sep-2023 MaaT Pharma and Skyepharma Complete Construction of Europe’s Largest Manufacturing Facility for Microbiome Ecosystem Therapies Businesswire
12-Sep-2023 MaaT Pharma and Skyepharma Complete Construction of Europe’s Largest Manufacturing Facility for Microbiome Ecosystem Therapies Businesswire
12-Sep-2023 AlgoTx Announces First Patients Dosed in US and European Arms of Phase II Clinical Trial of ATX01 in Rare Disease Erythromelalgia AlgoTherapeutix (AlgoTx)
12-Sep-2023 Kromek detectors used in Spectrum Dynamics’ new SPECT/CT scanner Kromek Group plc
12-Sep-2023 HUTCHMED Completes Patient Enrollment of a Bridging Study of Tazemetostat in Patients with Relapsed/Refractory Follicular Lymphoma in China HUTCHMED
12-Sep-2023 Sosei Heptares’ partner Neurocrine Biosciences Initiates Phase 1 Clinical Study Evaluating Effects of NBI-1117570 in Healthy Adults Sosei Group Corporation
12-Sep-2023 Clinical Trials in China: Unlocking the Potential of Advanced Therapies Presented by Novotech and Endpoints News Novotech
12-Sep-2023 Fertility Network responds to HFEA State of the Fertility Sector report Fertility Network
12-Sep-2023 Visual Components Robotics OLP launch enables digital production transformation Visual Components
12-Sep-2023 Navigating CMC Challenges in NBE and Therapeutic Antibody Development ProtaGene GmbH
12-Sep-2023 Celltrion celebrates a decade of biosimilar innovation in Europe Celltrion Healthcare
12-Sep-2023 CHEPLAPHARM opens swiss subsidiary and wins Agnes Wasem as Managing Director Cheplapharm AG
12-Sep-2023 Viral Vector Development Market: Projected US$ 4.1 Billion Valuation by 2033 for Gene Therapy Solutions | FMI MARKITWIRED
12-Sep-2023 Veterinary Disinfectant for Pets and Farms Market to Surpass Valuation of US$ 7.3 Billion by 2033 due to the Prevalence of Zoonotic and Food-Borne Diseases | FMI MARKITWIRED
12-Sep-2023 Personalized Medicine Market: Precision Healing Envisions a US$ 690.9 Billion Potential MARKITWIRED
12-Sep-2023 Heart Beat Irregularity Detection Device Market: Projected 4.5% CAGR Growth to US$ 20.7 Million by 2033 MARKITWIRED
12-Sep-2023 Remote Healthcare Market: Virtual Care’s Ascendance Towards a US$ 59 Billion Milestone by 2033 MARKITWIRED
12-Sep-2023 Healthy Horizons: The Future Landscape of a US$ 29.2 Billion Clinical Nutrition Market by 2033 MARKITWIRED